X27-24052-20467
3 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 209 / MD
- Registered
- 2021-12-10
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- N/A
Timeline
-
2021-02-09
Dose 1 — Pfizer-BioNTech
-
2021-03-04
Dose 2 — Pfizer-BioNTech
-
2021-12-08
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-12-10
Registered in v-safe
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-15
- 2021-12-22
- 2021-12-29
-
2022-01-05
Survey response — day 28, dose 3MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny nose.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-12
- 2022-01-19
- 2022-03-09
- 2022-06-08
- 2022-12-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-09 | Pfizer-BioNTech | No |
| 2 | 2021-03-04 | Pfizer-BioNTech | No |
| 3 | 2021-12-08 | Pfizer-BioNTech | Flu |
Free text
Release 10 — day 28, dose 3
Symptoms: Runny nose.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release